By comparing healthy and disease samples, we discovered evolutionary young Alu subfamilies that are downregulated in AD patients, such as AluYh9 and AluSp subfamilies, which have been found to be negatively associated with Tau pathologic burden in the human dorsolateral prefrontal cortex (Guo et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.